![William Martin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Martin was the founder of EpiVax, Inc., founded in 1998, where the title held was Chief Operating & Information Officer.
Mr. Martin is currently Director at Epivax Oncology, Inc. Former jobs include Manager-Clinical Data & Database Architect at PAREXEL International Corp.
and Manager-Clinical Data & Database Architect at Abt Associates, Inc.
| Unternehmen | Position | Beginn |
|---|---|---|
Epivax Oncology, Inc.
 Epivax Oncology, Inc. BiotechnologyHealth Technology Develops mutanome-directed, neo-epitope personalized therapeutic vaccines | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Abt Associates, Inc.
 Abt Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and consulting services | Corporate Officer/Principal | - |
EpiVax, Inc.
 EpiVax, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a bioanalytical CRO specializes in immunogenicity risk assessment for the pharmaceutical and biotechnology industries | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Abt Associates, Inc.
Abt Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and consulting services | Commercial Services |
EpiVax, Inc.
EpiVax, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a bioanalytical CRO specializes in immunogenicity risk assessment for the pharmaceutical and biotechnology industries | Commercial Services |
Epivax Oncology, Inc.
Epivax Oncology, Inc. BiotechnologyHealth Technology Develops mutanome-directed, neo-epitope personalized therapeutic vaccines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
